Abstract
AML-308 Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have